Cryptotanshinone modulates proliferation, apoptosis, and fibrosis through inhibiting AR and EGFR/STAT3 axis to ameliorate benign prostatic hyperplasia progression
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmacology
Reference43 articles.
1. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia;Alonso-Magdalena;Proc. Natl. Acad. Sci. U. S. A.,2009
2. Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription;Antony;Prostate,2014
3. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men;Belanger;J. Clin. Endocrinol. Metab.,1994
4. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18;Bello;Carcinogenesis,1997
5. Etiology, epidemiology, and natural history of benign prostatic hyperplasia;Bushman;Urol. Clin.,2009
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mechanisms and Efficacy of Chinese Herbal Medicines in Benign Prostatic Hyperplasia;Chinese Journal of Integrative Medicine;2024-08-27
2. Targeted therapies in HER2-positive breast cancer with receptor-redirected Arazyme-linker-Herceptin as a novel fusion protein;Breast Cancer;2024-08-09
3. Network pharmacology and experimental validation to explore the pharmacological mechanism of saw palmetto and its core ingredients in benign prostatic hyperplasia treatment;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-17
4. In vitro and vivo anti-tumor activity and mechanisms of the new cryptotanshinone derivative 11 against hepatocellular carcinoma;European Journal of Pharmacology;2024-05
5. Bisphenol A exposure stimulates prostatic fibrosis via exosome-triggered epithelium changes;Food and Chemical Toxicology;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3